Description
Tratamiento de cáncer de pulmón no microcítico (CPCNM) ALK positivo avanzado
MVASI® 100 mg | Solución Inyectable IV | Frasco Ámpula 4 mL
Forma Farmacéutica y Formulación:
PRINCIPIO ACTIVO: OMEGA 3 Y VITAMINAS
Somnolencia o mareos
FIGRAL 50MG TAB C10 ALGODON 25.00 G Tratamiento de cáncer de pulmónPRINCIPIO ACTIVO: SILDENAFILO DOSIS: 50 MG FORMA FARMACUTICA: 20 TABLETAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
